FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/03/2025
Voltar para busca
Dado oficial do USPTO
GENESYSTEM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42
Data de depósito
25/10/2021
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
KR
Examinador
FALK, JONATHAN ROBERT
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Genesystem Co., Ltd.
Representantes
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; reagents for analyzing proteins for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting proteins for scientific or laboratory purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; in vitro diagnostic reagents for scientific purposes; antibody reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; protein synthesis chemical reagent other than for medical purposes; reagents for nucleic acid amplification other than for medical purposes; chemical reagent for extracting nucleic acid other than for medical purposes; biological preparations for use in biotechnology other than medical use; reagents for cell straining other than medical use; reagents for cell transformation other than medical use; reagents for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing; diagnostic reagentsother than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis
Classe 5
Reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; veterinary diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic chemical reagents for medical use; diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical use; biological reagents for medical purposes; reagents for medical use; reagent paper for medical purposes; reagents for use in medical genetic testing; medical diagnostic reagents; chemical test reagents for medical use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes
Classe 10
genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes for gene verification; miniaturized sensors for use in gene analysis and diagnosis for medical purposes; real-time gene amplification equipment for medical use; medical genetic fragment analyzers; genetic testing apparatus for medical purposes; medical genetic analyzer; biopsy forceps; diagnostic testing apparatus for medical purposes for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; apparatus for taking blood samples; apparatus for DNA and RNA testing for medical purposes; DNA and RNA extraction and purification apparatus for medical purposes; medical immunoassay apparatus for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; medical instruments for application in human bodiesdiagnostic kit comprised of medical diagnostic apparatus for testing for virusesbacteriafungiparasiterickettsia and protista being a pathogen ; medical apparatus for clinical diagnosis for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; DNA diagnostic kit comprised of test chips for the analysis of body fluidspremix mixnuclease free waterblood sampling tubes and sealing tapes for medical purposes; clinical diagnostic kit comprised of test chips for the analysis of body fluidspremix mixnuclease free waterblood sampling tubes and sealing tapes for testing whole bloodserumsputumurinefecal fecestissuecellsDNA and RNA; patient medical monitoring instruments for monitoring DNA amplification results; medical instrumentsPCR system comprised ofmultiplex biochips for analysis of bodily fluidsdiagnostic kit comprised of medical diagnostic apparatus for testing for virusesbacteriafungiparasiterickettsia and protista being a pathogenPCR reagents; immunoadsorption columns for medical diagnostic use
Classe 42
Research and development of DNA chips; DNA screening for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA testing services to determine paternity being laboratory services; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; biological information check being genetic testing for medical research purposes; research in the field of gene analysis; genetic fingerprinting being DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; scientific research in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; biological research; biochemical research; biotechnological research relating to industry; development of biotechnology; research and development of technology for biotechnology; multiple nucleic acid analysis for scientific research purposes; protein analysis being scientific laboratory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/02/2025
FIMP
FINAL DISPOSITION PROCESSED
26/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/06/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/12/2023
GNFR
FINAL REFUSAL E-MAILED
19/12/2023
CNFR
FINAL REFUSAL WRITTEN
19/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/03/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
25/01/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/11/2022
RFNT
REFUSAL PROCESSED BY IB
10/10/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/09/2022
RFRR
REFUSAL PROCESSED BY MPU
20/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/08/2022
CNRT
NON-FINAL ACTION WRITTEN
04/08/2022
DOCK
ASSIGNED TO EXAMINER
02/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENESYSTEM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.